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INTRODUCTION 
THE PLACE AND RELEVANCE OF MANUAL SMALL INCISION 
CATARACT SURGERY (SICS) : 
  Modern cataract surgery aims to achieve an unaided visual acuity with 
rapid post surgical recovery and minimal surgical complications. This has 
been made possible with a smaller incision size, appropriate use of 
ophthalmic viscosurgical devices (OVD) and irrigating solutions, better 
instrumentation and technology. The advantages associated with 
phacoemulsification have made it the ideal technique for cataract surgery and 
the preferred one where resources are available. However, this technique 
cannot be employed as the standard procedure in developing countries due to 
certain reasons. Manual small incision cataract surgery offers similar 
advantages with the merit of wider applicability, better safety,  a shorter 
learning curve and lower cost. 
ROLE OF STERILE INTRAOCULAR IRRIGATING SOLUTION: 
 After intraocular surgery, corneal endothelial cellular morphologic 
changes are noted that are indicative of a stressed endothelial monolayer. The 
stressors implicated are instrumentation, loss of aqueous humor, endothelial 
contact with nuclear and cortical fragments, postoperative formation of 
oxygen free radicals. An ideal irrigating solution combines an energy source, a 
buffer and an antioxidant to maximally protect and nourish the intraocular 
structures. 
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WHY THIS STUDY?  
  Studies of the harmful effects of cataract surgery on corneal 
endothelial cells suggest that much of this damage is mediated by free 
radicals. Subsequent articles have emphasized the potential protective effects 
of various free radical scavengers
1-6
 and suggest that these substances may 
help prevent phacoemulsification-induced endothelial cell loss, a common 
and well-documented side effect of cataract surgery
7-13
. 
 Holst et al.
 
documented the formation of large amounts of free radicals 
and ultraviolet radiation in phacoemulsification, both in vivo and in vitro 
environments
14
. These formations were reduced by the addition of superoxide 
dismutase to the irrigating solution; however, they did not examine whether 
this reduction could effectively reduce endothelial cell loss.  
Other studies have shown a nonspecific beneficial effect of irrigating 
solutions containing glutathione (a free radical scavenger) in reducing cell 
loss from prolonged endothelial exposure to irrigating solutions 
2,5
. In a study 
in which a similar irrigation model in dogs was used, the investigators found 
no beneficial effect of glutathione 
15
. A study of the protective effects of 
different viscoelastic materials against endothelial damage by intraocular 
hydrogen-peroxide solutions
 
suggested that their protective effect may be due 
in part to free-radical scavenging properties 
3
.  
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Several researchers have compared the results of cataract surgery using 
a balanced saline ophthalmic irrigating solution to those obtained using 
solutions containing glutathione. Some have reported a protective effect of 
glutathione on the corneal endothelium, whereas others have found no effect 
16-18
. These studies, while important in determining the clinical use of 
glutathione, do not exclude other causes of endothelial damage, such as 
intraocular lens implantation, release of inflammatory substances in the eye, 
or release of lens particles. Also, these studies examined only one 
concentration of one free radical scavenger (glutathione), since it is the only 
commercially marketed solution in this category.  
 We elected to examine the role of ascorbic acid, a well-known 
scavenger of free radicals. Since this chemical is found in naturally high 
concentrations in normal aqueous, it is less likely to cause chemical damage 
to intraocular structures, and also has not been previously tested in the present 
setting to our knowledge 
22,23
.  
To elucidate the role of free radicals in endothelial cell loss secondary 
to manual SICS, we devised an experiment that would attempt to isolate the 
endothelial damage due to formation of free radicals during and following 
surgery as a result of manipulation and loss of natural aqueous humor. 
  
4 
 
HISTORY OF CATARACT SURGERY 
   5th century BC - Earliest written reference to cataract surgery is found 
in Sanskrit written by the Hindu surgeon Susruta. He practiced a type of 
cataract surgery known as couching or reclination, in which the cataractous 
lens was displaced away from the pupil to lie in the vitreous cavity in the back 
of the eye.  
In the Western world, recent excavations in Babylonia (Iraq), Greece, 
and Egypt have uncovered bronze instruments that would have been 
appropriate for cataract surgery. The first written description of the cataract 
and its treatment in the West appears in 29 AD in De Medicinae, the work of 
the Latin encyclopedist Celsus.  
History also records the use of bloodletting, antiphlogistics (agents to 
counteract inflammation and fever), and mercury to prevent or dissolve 
cataracts - all of which were unsuccessful.  
1748 - Modern cataract surgery; in which the cataract is actually 
extracted from the eye, introduced by Jacques Daviel in Paris. 
1753 - Samuel Sharp of London introduced the concept of 
intracapsular cataract surgery by using pressure with his thumb to remove the 
entire lens intact through an incision. 
 1867 - The use of sutures for cataract surgery, first described by Henry 
Willard Williams of Boston. 
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1884 - Anesthesia in the form of eyedrops (cocaine) was developed, 
obviating the hazards of general anesthesia and its postoperative 
complications 
1902 - Small suction cups (erysiphakes) were introduced for this 
purpose as well as various capsular forceps to grasp the lens for removal.  
1940s - Harold Ridley introduced the intraocular lens in England 
enabling efficient and comfortable visual rehabilitation became possible 
following cataract surgery 
1957 - Barraquer of Spain used alpha-chymotrypsin to enzymatically 
dissolve the zonules for removal of the lens.  
1961 - Cryo-surgery was introduced by Krawicz of Poland to remove 
the lens with a tiny probe that could attach by freezing a small area on the 
surface of the cataract.  
Late 1960s - Charles Kelman of New York developed a technique for 
emulsifying the lens contents using ultrasonic vibrations and aspirating the 
emulsified cataract.  
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STEPS OF MANUAL SICS 
1. Pupillary dilation and anaesthesia 
2. Superior rectus suture 
3. Fornix based conjunctival flap 
4. The incision 
- Opening in the sclera 
- The tunnel 
- Opening in the cornea 
5. Staining of anterior lens capsule (optional) 
6. Opening the anterior capsule (can opener capsulotomy / continuous 
curvilinear capsulorrhexis) 
7. Hydrodissection / hydrodelineation 
8. Mobilization of nucleus into the anterior chamber 
9. Removal of nucleus 
10. Cortical wash 
11. Insertion of artificial intraocular lens 
12. Removal of ocular viscosurgical devices 
13. Wound closure 
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ANATOMY OF THE CORNEA 
   The cornea is a transparent, avascular watch glass like structure 
forming the anterior one sixth of the eyeball. It forms the principle refractive 
surface, contains the intraocular pressure and provides a protective interface 
with the environment. These functions can be subserved by virtue of a 
specialized substructural organization. 
Histologically, the cornea is composed of five layers; 
 Epithelium 
 Bowman‟s membrane 
 Stroma or substantia propria 
 Descemet‟s membrane 
 Endothelium 
CORNEAL EPITHELIUM: 
It is stratified and non keratinized, 50 to 90 micron thick and consists 
of 5 or 6 layers of nucleated cells 
BOWMAN’S LAYER: 
 It is a narrow, acellular, homogenous zone, 8 to 14 micron thick, 
immediately adjacent to the basal lamina of the epithelium. It is relatively 
resistant to trauma due to the compact arrangement of collagen but once 
destroyed, it cannot regenerate. 
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1. Epithelium   2. Bowman‟s Membrane       3. Stroma   
4. Descemet‟s membrane  5.Endothelium  
9 
 
STROMA or SUBSTANTIA PROPRIA: 
 It comprises 90% of the total thickness of cornea, is 560 micron thick 
and comprises of regularly arranged lamellae of collagen bundles in a 
proteoglycan ground substance with cells called keratocytes. 
DESCEMET’S MEMBRANE: 
It is a thick basal lamina produced by the corneal endothelium and is 
10 to 12 micron thick. Its peripheral termination is marked by the schwalbe‟s 
line. The major protein type is collagen type IV. It regenerates readily 
following injury. 
ENDOTHELIUM: 
It consists of a single layer of hexagonal cells lying on the descemet‟s 
membrane, linked by hemidesmosomes and laterally to each other by tight 
junctional complexes. It has abundant mitochondria which aid in barrier 
function, protein synthesis and energy production.   
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Pleomorphism 
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Corneal endothelial cell turnover : 
  The cell density of the endothelium is around 6000 cells/mm
2
 at birth. 
The cell count falls by about 26% in the first year of life and a further 26% is 
lost over the next 11 years. The cell count comes down to 2400-3000 
cells/mm
2
 in young adults. The defect left by the dying cells is filled by 
enlargement (polymegathism) of the remaining cells. Hence, these cells vary 
in diameter from 18 to 20 micron early in life to 40 micron in aged. The 
response to direct wounding is to undergo „cell slide‟. If a sufficient number 
of endothelial cells are lost, it loses its function and the cornea imbibes water 
(decompensates) and becomes opaque. This corneal decompensation occurs 
only after more than 75% of the adult cells are lost; that is, when the 
endothelial cell count becomes less than 500 cells/mm
2
.  
The endothelial cells are best evaluated by specular microscopy. 
Deturgescence of the corneal stroma is controlled by the pumping action of 
the endothelial layer and can be monitored by measurement of central corneal 
thickness (pachymetry). Loss or damage of endothelial cells leads to an 
increase in corneal thickness, which may ultimately induce corneal 
decompensation and loss of vision. 
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SPECULAR MICROSCOPY 
The corneal specular microscope is a reflected-light microscope that 
projects light onto the cornea and images the light reflected from an optical 
interface of the corneal tissue, most typically the interface between the 
corneal endothelium and the aqueous humor. Depending on the instrument 
used, the projected light can be in the form of a stationary slit, a moving slit, 
or a moving spot and the optical design can either be non-confocal or 
confocal. 
 The goal of endothelial specular micrsocopy is to enable the status of 
the endothelium to be obtained by visual observation and morphometric 
analysis of the endothelial image. In general, the more the endothelial image 
varies from the normal appearance, the more compromised the endothelium, 
and the less able is the endothelium to provide its necessary functions that 
maintain corneal clarity. 
Optics of Specular Microscope: 
  Light striking a surface can be reflected, transmitted, or absorbed. 
Generally, some combination of the three effects occur, with the relative 
proportions depending on such conditions as the wavelength of the light, the 
relative transparency of the medium below its surface, and the relative 
refractive indices on each side of the surface. Of primary importance in 
clinical specular microscopy is the light that is reflected specularly (i.e. 
“mirror-like”) where the angle of reflection is equal to the angle of incidence. 
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As light strikes the posterior corneal surface, almost all of it is 
transmitted into the aqueous humor. Because there is a change in index of 
refraction at the endothelium-aqueous humor interface, about 0.022 per cent 
of the total incident light is reflected; this reflected light is captured by the 
clinical specular microscope and forms the endothelial image. 
Examination of corneal endothelium: 
   Both qualitative and quantitative assessments of the corneal 
endothelium can be made. Qualitative cellular analysis identifies abnormal 
endothelial structures and grades the endothelium either according to the 
number or size of the abnormal structures present or on the basis of an overall 
visual assessment of endothelial appearance. The goal is to provide a 
subjective evaluation of the endothelium, not to assign a precise numerical 
value to the specular photomicrograph. This type of analysis provides a rapid 
clinical evaluation of the endothelium to assess the risks of intraocular 
surgery, to establish a diagnosis, or to decide upon treatment. Complete 
qualitative analysis requires that several parameters be evaluated including 
cell conformation, cell boundaries and their intersections, configuration of the 
dark boundary, and the presence of acellular structures. One must be careful 
to eliminate optical artifacts from consideration when performing either 
qualitative or quantitative analysis of the corneal endothelium. 
14 
 
 
 
Variations in the configuration of the corneal endothelium. 
 A- Elongated cells  
 B-Cell having scalloped edges  
 C and D- Round cells 
 E- Square cell  
 F- Triangular cell. 
15 
 
 
Miscellaneous endothelial structures. 
   A- Isolated smooth excrescences (cornea guttata) 
   B- Multiple coalesced excrescences.  
   C and D- Intracellular bright structures.  
   E- Pigmented endothelial deposits.  
   F and G- intracellular dark structures.  
   H- intercellular dark structures, believed to be invading inflammatory cells. 
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The clinical specular microscope can identify morphologic variations 
in endothelial cell configuration, cell surface properties, and intercellular 
boundaries, as well as the presence of numerous intracellular structures. 
Although the nature and significance of many of these abnormalities are not 
presently known, their recognition represents an initial step in the elucidation 
of their pathophysiological significance. 
Various morphological parameters can also be quantified. These 
include cell size (cell area or cell density), polymegathism (variation of cell 
size such as coefficient of variation of mean cell area), pleomorphism 
(variation of cell shape such as percent of hexagonal cells or coefficient of 
variation of cell shape), cell perimeter, average cell side length, and cell 
shape.  To date only cell size, pleomorphism, and polymegathism and several 
variables related to these parameters have proven useful in determining 
endothelial status. 
Two equivalent parameters have been used to quantify endothelial cell 
size. They are mean cell area and cell density (or cell count). Cell area has 
most often been expressed in units of µm² per cell and cell density in units of 
cells per mm². 
Fixed Frame Analysis of Cell Size 
In fixed frame analysis one counts the number of cells within a frame 
or window of constant area. All cells lying completely within the frame are 
counted as whole cells. However, along the boundary of the frame there are 
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many cells that lie only partly in the frame, and for these cells it is usually 
impossible to determine the fraction of the cellular area that lies within the 
borders of the frame. Each cell that is only partially within the frame is 
counted as one half-cell regardless of the fractional area of that cell located 
within the frame. The total number of cells (the cell count) is then taken as the 
sum of the number of whole and half-cells within the frame. To speed up the 
counting process one commonly invokes a symmetry principle and counts all 
cells cut by two sides of the frame as whole cells and does not count those 
cells cut by the other two sides of the frame. As long as the number of 
boundary cells is small compared to the total number of whole cells within the 
frame, and cellular pleomorphism is not too great, this method can give 
reasonably accurate values for mean cell size. The size is obtained by dividing 
the cell count by the area of the frame and expressed as cell density in cells 
per mm². The area of the frame must be referred to the endothelium. This is 
accomplished by dividing the actual area of the frame by the square of the 
linear magnification of the specular microscope, and if the cells were counted 
from an enlargement of the negative, by the square of the linear magnification 
of the enlargement. One can also divide the area by the cell count and report 
mean cell area as well. In practice, except for very rough estimates of cell 
count, a minimum of 35 contiguous cells should lie within the counting frame, 
although for most studies it is preferable to have 50 to 100 cells within the 
counting frame. Otherwise the errors associated with the counting method 
itself will generally be too large to provide meaningful numbers. 
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Variable Frame Analysis of Cell Size 
Variable frame analysis, originally proposed by Laing, is most 
conveniently done using a computer based analysis system. This method 
eliminates the problem of counting fractional cells along the boundary, thus 
providing a more accurate determination of mean cell size than fixed frame 
analysis, again assuming that cellular pleomorphism is not too great and that 
the cell sample is representative of the area under study. 
In variable frame analysis, one first measures the variable area 
occupied by an integral number of cells by tracing around a contiguous group 
of cells with a mouse. The user then marks each cell by clicking it with the 
mouse. The computer then calculates the cell density by dividing the number 
of marked cells by the area of the frame. An equivalent value, the mean cell 
area, can also be obtained by dividing the frame area by the number of cells 
that have been circumscribed. 
Using variable frame analysis, errors due to the counting method are 
very small as compared to fixed frame analysis so that many fewer cells must 
lie within the frame. Furthermore, with variable frame analysis, additional 
information can be obtained. If one traces around the smallest cell in the 
image and marks it, the computer calculates the cell density assuming that all 
cells are this small. If one then traces around the largest cell in the image and 
marks it, the computer calculates the cell density assuming that all cells are 
this large. These two numbers give the range of cell densities (or the range of 
19 
 
cell areas) that exist in this image providing more information regarding the 
endothelium than if only the mean cell density is obtained. 
 
Topcon Specular microscope SP – 2000P 
 
Center cell method  - variable frame analysis 
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STERILE INTRAOCULAR IRRIGATING SOLUTIONS 
The intraocular irrigating solutions available are 
1. Lactated Ringer‟s solution 
2. Balanced salt solution (BSS) 
3. BSS plus 
 The major role of irrigating solutions during intraocular surgery, 
especially manual SICS are during cortical wash, removal of OVDs and 
formation of anterior chamber at the end of the surgery. 
 
Chemical composition of human aqueous humor, vitreous humor, BSS 
PLUS
 
 intraocular irrigating solution and BSS intraocular irrigating 
solution (all concentrations expressed in mmol/L or mEq/L solution)
24 
21 
 
The primary purpose of an intraocular irrigating solution is to maintain 
both the anatomic and physiologic integrity of intraocular tissues. Many 
physiologic studies performed on the corneal endothelium have confirmed 
that a solution with a chemical composition similar to aqueous and vitreous 
humor provides the best protection for intraocular tissues. 
Glutathione (GSH and GSSG) is one of the body’s natural 
antioxidants. Free-radicals (by-products of oxidation) are capable of inflicting 
serious damage to the corneal endothelium and other delicate intraocular 
structures during ophthalmic surgery. There is evidence to suggest that 
glutathione is an effective free-radical scavenger. Glutathione also maintains 
the junctional complexes of corneal endothelial cells
25
 and protects the 
integrity of the blood-aqueous barrier 
26
.The tissues within the eye are highly 
sensitive to depletion of cellular glutathione levels. Depletion of cellular 
glutathione can result in cell apoptosis.
27
 BSS PLUS Solution has the ability 
to deliver a continuous supply of glutathione to the surgical site. 
Sodium bicarbonate is the body’s natural buffer. It is the major ion in 
the formation of aqueous humor and is vital for maintaining the blood-
aqueous barrier. Sodium bicarbonate is also essential for maintaining retinal 
function. Studies have shown that omission of bicarbonate leads to significant 
alterations in both light-induced ERG potentials
 
and metabolism of the 
isolated rat retina 
28-29
. 
  
22 
 
Glucose is the primary energy source of cellular function. Glucose 
helps maintain transparency of the cornea and lens and is critical for 
maintaining optimal retinal functions. Endothelial and retinal cells can rapidly 
become stressed or compromised when deprived of nourishment. Other 
intraocular irrigating solutions do not contain the ions, nutrients and 
substrates necessary to sustain healthy, normal functioning of ocular tissues. 
This is why a complete perfusion solution makes good sense in ocular 
procedures.  
Thus BSS plus is considered an ideal intraocular irrigating solution. In 
developing countries, where economical constraints play a major role in 
provision of resources, Lactated Ringer‟s solution is still used as the 
intraocular irrigating solution.  
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RESEARCH BACKGROUND 
  Studies by Koskela et al have shown ascorbic acid, as an adaptive 
mechanism to protection by solar radiation 
30
.Ascorbic acid is known to exist 
in high concentration in the aqueous humor of the eye in many species. It has 
been observed that diurnal mammals have a very high concentration in 
aqueous humor whereas nocturnal mammals do not. It has been hypothesized 
that ascorbic acid protects the eye from the harmful effects of sunlight. The 
results of the study showed that of two closely related species of spiny mice, 
the diurnal species (Acomys russatus) had a concentration in aqueous humor 
that is 35 times higher than that of the nocturnal species (Acomys cahirinus). 
Studies of these two species may be fruitful to extend what is known about 
adaptation of the eye to protect itself from intense solar radiation. 
Subsequent workers have shown that ascorbic acid is found in aqueous 
humor in concentrations 25 times that in plasma in other species, including 
humans
31-36
.  Linner found that the ciliary body of rabbit cleared its plasma of 
ascorbic acid and pumped it into the posterior chamber along with newly 
formed aqueous humor
37
. This efficient process is carried out by sodium - 
ascorbate cotransporter in the ciliary body
38
. 
Rubowitz et al conducted an experiment to examine the role of 
ascorbic acid in reducing corneal endothelial cell loss secondary to high-
energy ultrasound energy during phacoemulsification surgery
30
. Seventeen 
rabbit eyes were subjected to prolonged phacoemulsification within the 
anterior chamber, without manipulation or damage to other ocular structures. 
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In nine eyes, a balanced salt ophthalmic solution was used as the 
phacoemulsification irrigation solution, and in eight eyes the solution plus 
0.001 M ascorbic acid was used, all other parameters being identical between 
the two groups. Specular microscopy was performed in all eyes before and 1 
week after surgery. The animals were then killed, and the corneas were 
examined histologically.  
Results showed no significant difference in preoperative endothelial 
cell counts between the two groups. Postoperative cell counts were reduced 
by 453.9 ± 233.3 (SEM) cells/mm
2
 in the solution-alone group versus 123.2 ± 
196.4 (SEM) cells/mm
2
 in the solution-plus-ascorbic acid group, (P = 0.011). 
Corneal histology revealed a marked difference in endothelial cell 
morphology between the two groups. They concluded that the addition of 
ascorbic acid to the irrigation solution significantly reduced the amount of 
endothelial cell loss during phacoemulsification by approximately 70%. This 
was thought to be due to the free-radical scavenging properties of ascorbic 
acid. Further studies were warranted to find the optimal concentrations and 
combinations of free radical scavengers to be used in phacoemulsification 
irrigation solutions. It was previously found by the authors that the normal 
interexamination variation between endothelial cell counts was approximately 
±5%, and postoperative results showing minor increases in endothelial cell 
counts were probably due to this variation.  
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Mathew et al determined endothelial cell loss and central corneal 
thickness in patients with and without diabetes after manual SICS
40
. There 
was a steady drop in the endothelial density in both the groups 
postoperatively, with the percentage of endothelial loss at 6 weeks and 3 
months being 9.26 +/- 9.55 and 19.24 +/- 11.57, respectively, in patients with 
diabetes and 7.67 +/- 9.2 and 16.58 +/- 12.9, respectively, in controls. The 
percentage of loss between 6 weeks and 3 months was found to be of 
significant difference (P=0.023). In both the groups, an initial increase in CCT 
till the second postoperative week was followed by a reduction of CCT in the 
subsequent follow-up (sixth week) and a further reduction in the last follow-
up (3 months). The change in CCT between the second and sixth weeks was 
significantly higher in the diabetic group (P = 0.045). It was concluded that 
the diabetic endothelium was found to be under greater metabolic stress and 
had less functional reserve after manual SICS than the normal corneal 
endothelium. 
Studies by Ventura et al compared the corneal thickness and 
endothelial density before and after cataract surgery
41
. All patients had 
significant postoperative corneal swelling on the day after surgery; 
preoperative values were restored by 3 and 12 months, even though 
significant endothelial cell losses had occurred. No correlation was found to 
exist between central corneal thickness and central corneal endothelial cell 
numerical density. Measurements estimated by ultrasonic pachymetry were 
more variable and significantly higher than those determined by optical low 
coherence reflectometry. It was concluded that as long as the numerical 
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density of the corneal endothelial cells does not fall below the physiological 
threshold, a moderate decrease in this parameter does not compromise the 
pumping activity of the layer as a whole. 
A healthy cornea is able to compensate rapidly for transient increases 
in central corneal thickness after cataract surgery, but such is not the case 
when the endothelium is diseased. In patients with endothelial polymegathism 
the return to preoperative values of corneal thickness is significantly slower 
than in those with a normal endothelium
42
.  
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AIM & OBJECTIVE OF THE STUDY 
Aim of study: 
 To determine the role of ascorbic acid in corneal endothelial 
protection during manual small incision cataract surgery (SICS). 
Primary objective: 
 To compare the corneal endothelial cell loss after manual SICS with 
and without ascorbic acid 
Secondary objectives: 
 To compare the morphology of corneal endothelial cells before and 
after manual SICS, with and without ascorbic acid 
To compare the central corneal thickness before and after manual 
SICS, with and without ascorbic acid 
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INCLUSION AND EXCLUSION CRITERIA 
INCLUSION CRITERIA : 
1. Age – 40 to 80 years 
2. Senile cortical cataract with grade I-II NS  
3. Endothelial cell count > 1000 
4. Clear cornea on slit lamp examination 
EXCLUSION CRITERIA : 
1. Age > 80 years 
2. Endothelial cell count < 1000 
3. Grade III-IV nuclear sclerosis 
4. Diabetes 
5. Herpetic scars 
6. Elevated IOP 
7. Prior trauma 
8. Prior ocular surgeries 
9. Corneal endothelial dystrophies 
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METHODOLOGY 
(MATERIALS & METHODS) 
MATERIALS USED: 
1. Information sheet* 
2. Consent form** 
3. Slit lamp biomicroscopy for anterior segment examination and grading 
of cataract 
4. Schiotz tonometer for intra ocular pressure measurement 
5. Non-contact specular microscope (Topcon SP – 2000P) for corneal 
endothelial analysis and central corneal thickness measurement. 
6. Biochemistry department of the Institute for blood glucose estimation 
7. Parentral ascorbic acid (1 ampoule containing 100mg in 5 ml) 
8. Ringer‟s lactate solution as sterile intraocular irrigating solution 
 
 
* - Appendix I   
** - Appendix II   
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METHODS: 
After obtaining clearance from the Institution ethics committee, 
patients visiting the hospital for cataract surgery were selected for the study 
based on inclusion and exclusion criteria. Informed consent was obtained and 
patients were randomly allocated into the control and case groups. 
PREOPERATIVE EVALUATION: 
Patients selected based on inclusion and exclusion criteria were 
examined using the slit lamp biomicroscope to ensure a healthy anterior 
segment and for the purpose of cataract grading. Intra ocular pressure 
measurements were obtained using Schiotz tonometer. Patients diagnosed 
with diabetes mellitus were ruled out of the study. Subsequently, patients 
were examined with the non-contact specular microscope to assess 
endothelial cell count, cell morphology and central corneal thickness. 
INTRA OPERATIVE PROCEDURE: 
  Ringer‟s lactate solution was used as the sterile intraocular irrigating 
solution during cataract surgery. 5ml containing 100 mg of parentral ascorbic 
acid was added to 500ml of ringer‟s lactate solution to obtain a final 
concentration of 0.2mg/ml which equals the concentration of ascorbic acid 
found in human aqueous humor. 
      The patients were operated upon by a single surgeon to rule out 
surgeon‟s factors contributing to endothelial cell loss during surgery. All 
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patients were subjected to manual small incision cataract surgery with 
standard posterior chamber intraocular lens implantation. Adequate use of 
ocular viscosurgical devices was ensured to prevent corneal endothelial cell 
loss as a result of instrumentation.  
   Ringer‟s lactate solution without ascorbic acid was used for controls 
and ringer‟s lactate solution with ascorbic acid was used for cases. As it was a 
single blinded study, the participants were unaware of whether they were 
subjected to the experimental drug or not. The irrigating solution was used 
during cortical wash, removal of OVD and anterior chamber formation at the 
end of surgery. 
POST OPERATIVE FOLLOWUP: 
   All patients were prescribed same topical antibiotic/steroid eyedrops 
during the postoperative period. All eyes were examined on the first post-
operative day and those with striate keratopathy were ruled out of the study. 
This was because striate keratopathy was a common complication of cataract 
surgery due to many other reasons in addition to corneal endothelial cell loss.  
   Post-operative measurements of corneal endothelial cell count, cell 
morphology and central corneal thickness were obtained on the first post-
operative day and after one week during the first follow up.  
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STATISTICAL ANALYSIS: 
 The data collected during the course of the study was entered in an 
excel file and computed using a statistical software package (Graph pad Prism 
5). The statistical analysis method used was unpaired t-test. Parameters 
studied were; 
 Comparison of preoperative endothelial cell count between controls 
and cases 
 Comparison of preoperative cell morphology between controls and 
cases 
 Comparison of preoperative CCT between controls and cases 
 Comparison of post operative endothelial cell count between cases and 
controls 
 Comparison of post operative cell morphology between cases and 
controls  
 Comparison of post operative CCT between cases and controls 
 Comparison of follow up corneal endothelial cell count between cases 
and controls 
 Comparison of follow up cell morphology between cases and controls 
 Comparison of follow up CCT between cases and controls 
 Comparison of pre and post operative reduction in endothelial cell 
count between cases and controls 
 Comparison of variation in pre and post operative  cell morphology 
between cases and controls 
 Comparison of variation in pre and post operative CCT between cases 
and controls 
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The analysed data was depicted using a box and whisker plot. In 
descriptive statistics, a box plot or boxplot (also known as a box-and-
whisker diagram or plot) is a convenient way of graphically depicting 
groups of numerical data through their five-number summaries: the smallest 
observation (sample minimum), lower quartile (Q1), median (Q2), upper 
quartile (Q3), and largest observation (sample maximum). A boxplot may also 
indicate which observations, if any, might be considered outliers. 
 
Boxplots display differences between populations without making any 
assumptions of the underlying statistical distribution: they are non-parametric. 
The spacings between the different parts of the box help indicate the degree of 
dispersion (spread) and skewness in the data, and identify outliers. Boxplots 
can be drawn either horizontally or vertically. 
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Figure 1: Comparison of preoperative endothelial cell count between 
controls and cases: 
 
Mean ± SEM for RL group 2531 ± 57.00 
Mean ± SEM for RL+AA group 2420 ± 54.99 
Statistical test method Unpaired T-Test 
P-Value 0.1617 (P > 0.05) 
Interpretation No statistical difference between 
groups 
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Figure 2: Comparison of preoperative cell morphology (cell variance) 
between controls and cases: 
 
 
Mean ± SEM for RL group 24.71 ± 0.95 
Mean ± SEM for RL+AA group 26.56 ± 0.97 
Statistical test method Unpaired T-Test 
P-Value 0.1737 (P > 0.05) 
Interpretation No statistical difference between 
groups 
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Figure 3: Comparison of preoperative Central Corneal Thickness 
between controls and cases: 
 
 
Mean ± SEM for RL group 513.4 ± 3.527   
Mean ± SEM for RL+AA group 512.6 ± 3.464   
Statistical test method Unpaired T-Test 
P-Value 0.8759 (P > 0.05) 
Interpretation No statistical difference between 
groups 
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Figure 4: Comparison of Post-Operative Corneal Endothelial Cell Count 
in Control and Cases 
 
 
Mean ± SEM for Pre-Op 2180 ± 49.56 
Mean ± SEM for Post-Op 2341 ± 56.15 
Statistical test method Unpaired T-Test 
P-Value 0.0339 (P < 0.05) 
Interpretation Significant statistical difference  
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Figure 5: Comparison of Post-Operative Cell Variance between control 
and interventional group: 
 
Mean ± SEM for Pre-Op 32.27 ± 1.128 
Mean ± SEM for Post-Op 27.79 ± 0.893 
Statistical test method Unpaired T-Test 
P-Value 0.0022 (P <0.05) 
Interpretation Significant statistical difference  
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Figure 6: Comparison of Post operative CCT between control and 
interventional groups: 
 
Mean ± SEM for Pre-Op 529.5 ± 3.490 
Mean ± SEM for Post-Op 534.5 ± 3.527 
Statistical test method Unpaired T-Test 
P-Value 0.2941 (P > 0.05) 
Interpretation No Significant statistical difference  
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Figure 7: Comparison of Follow-Up Corneal endothelial cell count 
between Control and Interventional groups: 
 
 
Mean ± SEM for Pre-Op 2186 ± 48.21 
Mean ± SEM for Post-Op 2337 ± 48.33 
Statistical test method Unpaired T-Test 
P-Value 0.0286 (P < 0.05) 
Interpretation Significant statistical difference  
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Figure 8: Comparison of Follow-Up Cell Variance between Control and 
Interventional Groups: 
 
 
Mean ± SEM for Pre-Op 33.28 ± 1.009 
Mean ± SEM for Post-Op 27.08 ± 0.8276 
Statistical test method Unpaired T-Test 
P-Value 0.0001 (P < 0.05) 
Interpretation Significant statistical difference  
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Figure 9: Comparison of Follow-Up Central Corneal Thickness between 
Control and Interventional groups: 
 
 
Mean ± SEM for Pre-Op 532.2 ± 3.156 
Mean ± SEM for Post-Op 534.4 ± 3.160 
Statistical test method Unpaired T-Test 
P-Value 0.6357 (P > 0.05) 
Interpretation No significant statistical difference  
 
  
R
L 
gr
ou
p
R
L 
+ 
AA
 g
ro
up
400
450
500
550
600
650
F
o
llo
w
-U
p
 C
C
T
45 
 
Figure 10: Comparison of Pre-Op and Post-Op Endothelial cell reduction 
between Control and interventional groups: 
 
 
Mean ± SEM for RL group 351 ± 37.63 
Mean ± SEM for RL+AA group 79.19 ± 39.68 
Statistical test method Unpaired T-Test 
P-Value < 0.0001 (P < 0.5) 
Interpretation Significant statistical difference  
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Figure 11: Comparison of Pre-Op and Post-Op Cell Variance difference 
between control and interventional groups: 
 
Mean ± SEM for RL group 7.560 ± 0.7457 
Mean ± SEM for RL+AA group 1.227 ± 0.7497 
Statistical test method Unpaired T-Test 
P-Value < 0.0001 (P < 0.5) 
Interpretation Significant statistical difference  
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Figure 12: Comparison of Pre-Op and Post-Op CCT difference between 
Control and Interventional groups: 
 
Mean ± SEM for RL group 16.07 ± 2.294 
Mean ± SEM for RL+AA group 21.87 ± 1.919 
Statistical test method Unpaired T-Test 
P-Value 0.0544 (P > 0.05) 
Interpretation No Significant statistical difference  
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RESULTS 
150 patients were enrolled in the study, of which 75 were enlisted to 
receive lactated ringer‟s solution without ascorbic acid (control group)  and 
the remaining 75 to lactated ringer‟s solution with ascorbic acid 
(interventional group) as the intraocular irrigating solution during manual 
SICS. All patients were reviewed on the first post operative day and 1 week 
after surgery. 
The preoperative corneal endothelial cell count, cell variance and CCT 
in both the groups were comparable.  The endothelial cell count in control 
group was 2531 ± 57.00 vs 2420 ± 54.99 in the interventional group showing 
no statistical difference, p=0.1617 (fig.1). The cell variance based on 
morphology in the control group was 24.71 ± 0.95 vs 26.56 ± 0.97 in the 
interventional group with no significant statistical difference, p=0.1737  
(fig.2). The CCT in the control group was 513.4 ± 3.527 vs 512.6 ± 3.464  in 
the interventional group with no significant statistical difference, p=0.8759 
(fig.3). Thus both the groups were comparable with respect to the above 
parameters preoperatively. 
The above parameters were measured on the first postoperative day in 
both the groups. Differences existed with regards to the cell count and cell 
variance, however the changes in CCT showed a similar pattern in both the 
groups. The endothelial cell count in the control group was 2180 ± 49.56 
(13.8% reduction) vs 2341 ± 56.15 (3.26% reduction) in the interventional 
group. The above values were statistically significant (p=0.0339) (fig.4). Cell 
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variance in the control group was 32.27 ± 1.128 (30.59% increase) vs 27.79 ± 
0.893 (4.63% increase) in the interventional group making the difference 
statistically significant (p=0.0022) (fig.5). The CCT measured was 529.5 ± 
3.490 (3.04% increase) in the control group and 534.5 ± 3.527 (4.09% 
increase) in the interventional group, showing no statistically significant 
increase (p=0.2941) (fig.6). 
All subjects were followed up one week after surgery. The results 
obtained during the first week of follow up were similar to those obtained on 
the first post operative day. There was no furthur reduction in the corneal 
endothelial cell count or increase in cell variance and CCT in both the control 
and interventional groups. However the difference in parameters between 
both the groups continued to exist. The endothelial cell count in the control 
group was 2186 ± 48.21 and interventional group was 2337 ± 48.33. Both 
groups showed a statistical difference in the cell count (p=0.0286) (fig.7). The 
cell variance in the control group was 33.28 ± 1.009 vs 27.08 ± 0.8276 in the 
interventional group, p=0.0001 (fig.8). The CCT values in the control and 
interventional group was 532.2 ± 3.156 and 534.4 ± 3.160 respectively, with 
no statistical difference (p=0.6357) (fig.9). 
The reduction in the corneal endothelial cell count between the control 
group (351 ± 37.63) and interventional group (79.19 ± 39.68) was statistically 
significant, p<0.0001 (fig.10), implying that ascorbic acid had a role in the 
protection of corneal enodthelium during cataract surgery. The increase in cell 
variance in the control group was 7.560 ± 0.7457 vs 1.227 ± 0.7497 in the 
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interventional group (p<0.0001) (fig.11). This showed that addition of 
ascorbic acid reduced the degree of pleomorphism and polymegathism in the 
post operative period. However the CCT increase in both the groups showed 
no statistical difference, 16.07 ± 2.294 and 21.87 ± 1.919 for controls and 
cases respectively (p=0.0544) (fig.12). The CCT increase was similar in both 
the groups and ascorbic acid had no role in the reduction of postoperative 
corneal swelling. 
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DISCUSSION 
L-Ascorbic acid, an antioxidant present abundantly in aqueous humor is 
thought to confer protection against the harmful effects of photochemical 
and oxidation reactions involving oxygen and its radicals. During manual 
SICS, this antioxidant is lost with aqueous humor and is replaced with 
irrigating solution which doesnot contain ascorbic acid thereby rendering the 
postoperative endothelium to greater oxidative stress and damage. The 
damage is increased further by the release of inflammatory mediators and 
exposure to sunlight following cataract surgery. 
 This study has shown that, although there is endothelial cell loss 
following cataract surgery in both the control and interventional groups, the 
amount of cell loss in the RL+AA group is much less when compared to RL 
only group. This can be attributed to the free radical scavenging activity of 
ascorbic acid, which prevents endothelial cell loss due to damage by reactive 
oxygen species during and following manual small incision cataract surgery. 
Observation on changes in endothelial cell morphology has shown an 
increase in cell variance in both the groups. However, the increase in 
RL+AA group is less when compared to RL only group. This can be 
attributed to the reduced endothelial cell loss and hence the reduced 
requirement of the endothelial cells to undergo „cell slide‟ and enlargement 
when subjected to ascorbic acid. 
  
52 
 
The central corneal thickness was found to increase in both the 
groups to the same extent and was not influenced by the addition of ascorbic 
acid. This might suggest that as long as the endothelial cell density is within 
the acceptable range, even significant changes in their number doesnot affect 
the occurence of postoperative corneal swelling. 
The first follow up parameters recorded one week following surgery 
showed no significant change when compared with the parameters recorded 
on the first postoperative day. The endothelial cell count showed no further 
decrease  and there was no change in the cell variance and central corneal 
thickness. This can be attributed to the active secretion of ascorbic acid into 
the anterior chamber following cataract surgery, hence preventing further 
loss of corneal endothelial cells. The endothelial cell count could not 
increase due to obvious reasons that the human corneal endothelium is 
incapable of undergoing mitosis. 
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CONCLUSION 
Ascorbic acid has a protective effect over the human corneal endothelial 
cells during manual SICS. The protective effect is due to its free radical 
scavenging properties thus protecting the endothelium from oxidative 
damage. 
Ascorbic acid was used in a constant concentration of 0.2mg/ml 
throughout the study. Further studies are warranted to find out the optimal 
and most effective concentration of ascorbic acid that could be combined 
with the intraocular irrigating solution. 
 The follow up period of this study was short. Further studies with 
long term follow up can establish the reversal of post operative corneal 
swelling and factors influencing it, in addition to the long term effects of 
oxidative damage on the corneal endothelium.  
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APPENDIX I 
INFORMATION SHEET 
 We are conducting a study on the beneficial effect of ascorbic acid to 
the corneal endothelial cells during cataract surgery at the Regional 
institute of Ophthalmology, Chennai. 
 We are selecting cases based on the eligibility criteria and if you are 
found to be eligible, your eyes may be subjected to the drug during 
cataract surgery. 
 We will also be doing additional investigations before and after 
surgery to assess the effectiveness of intervention. 
 The privacy of the patients in the research will be maintained 
throughout the study. In the event of any publication or presentation 
resulting from the research, no personally identifiable information will 
be shared. 
 Taking part in the study is voluntary. You are free to decide whether to 
participate in this study or to withdraw at any time, your decision 
willnot result in any loss of benefits to which you are otherwise 
entitled. 
 The results of the study may be intimated to you at the end of the study 
period or during the study if anything is found abnormal which may 
aid in management or treatment. 
 
Signature of investigator                                         Signature of participant 
Date: 
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APPENDIX II 
CONSENT FORM 
TITLE OF STUDY – Role of ascorbic acid in corneal endothelial 
protection during small incision cataract 
surgery 
NAME :                                                        DATE  :                                                                                                                                        
AGE     :                                                      IP NO :                                                                                           
SEX      :                                                    STUDY  NO :                                                                                                                    
 I have understood all the details clearly and I am willing to 
participate in the study. 
 I am willing to undergo cataract surgery and I understand that during 
the surgery, I might be subjected  to irrigating solution with ascorbic 
acid in it. 
 I also agree to undergo the necessary investigations required for the 
study. 
 I understand that I am at the risk of complications pertaining to 
cataract surgery as explained by the doctor, and still agree to undergo 
the surgery. 
 As the adverse effects of ascorbic acid inside the eye have not been 
proven, I also understand that  I am at the risk of developing new 
complications if any. 
 I whole heartedly agree to participate in this study without 
compulsion from others and I am aware that I can withdraw from 
this study at any point of time and so doing will not affect my 
treatment in any way. 
 Hence with total awareness and freedom of choice, I agree to 
participate in this study.   
SIGNATURE                                      
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APPENDIX III 
PROFORMA 
RL ONLY / RL + AA 
Name                :                                           OP number :                                                
Age / Sex          :                                               IP number  :                                               
Date of surgery :                                               Date of discharge :                       
Eye operated     :                                               Diagnosis     : 
Syst. Complications – 
IOP (schiotz)            - 
  PRE OP POST OP 1 WEEK 
Snellen’s chart Vn with PH    
Specular 
microscopy 
CCT    
 N    
 Min    
 Max    
 Avg    
 CV    
 CD    
Others (if any)     
 
  
